CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory to Sales
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kewaunee Scientific Corporation  (NASDAQ: KEQU)
Other Ticker:  
 
 

Kewaunee Scientific Accounts Receivables Turnover Ratio from the third quarter 2025 to the third quarter 2024

Quarterly Results, Trends, Rankings, Statistics



 
Kewaunee Scientific Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2025 to a ratio of 4.67, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Kewaunee Scientific in Jan 31 2025 quarter, has decreased to 78 days, compared to 79 days, in the Oct 31 2024 quarter.

If we take a look into Healthcare sector 261 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2042, from overall ranking in the second quarter 2025 at 2632.

What is Receivable Turnover Ratio?
What is Kewaunee Scientific Corporation Selling?


What is Receivable Turnover Ratio?




KEQU Receivables Turnover Ratio (Jan 31 2025)
III. Quarter		 (Oct 31 2024)
II. Quarter		 (Jul 31 2024)
I. Quarter		 (Apr 30 2024)
IV. Quarter		 (Jan 31 2024)
III. Quarter
Y / Y Receivable Change 39.68 % -1.68 % 2.55 % -2.21 % -6.54 %
Y / Y Revenue Change 44.21 % -5.09 % -2.92 % 8.62 % -24.32 %
Receivable Turnover Ratio (TTM) 4.67 4.64 4.68 4.74 4.61
KEQU's Total Ranking # 2042 # 2632 # 2666 # 293 # 272
Accounts Receivable average collection period days 78 79 78 77 79
Seq. Receivable Change 37.09 % -3.81 % -3.37 % 9.62 % -3.5 %
Seq. Revenue Change 41.38 % -1.13 % -19.02 % 27.4 % -6.95 %

New: More KEQU's historic Receivables Turnover Ratios >>

Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 11
Healthcare Sector # 262
Overall Market # 2042

Receivable Turnover Ratio Statistics
High Average Low
5.25 4.68 4.12
(Apr 30 2018)   (Apr 30 2022)





KEQU Company Profile • Back to KEQU Efficiency Comparisons • Compare KEQU Receivables Turnover Ratio to its Competitors

Financial Statements
Kewaunee Scientific's Accounts Receivable $ 57 Millions Visit KEQU's Balance sheet
Kewaunee Scientific's Sales TTM $ 219 Millions Visit KEQU's Income Statement
Sources of KEQU's Revenues Visit KEQU's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KEQU's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KEQU's Growth Rates KEQU's Roa KEQU's Inventory Turnover Ratio KEQU's Dividend Comparisons
KEQU's Profitability Ratios KEQU's Roi KEQU's Asset Turnover Ratio KEQU's Dividend Growth
KEQU's Valuation Ratios KEQU's Roe KEQU's Financial Strength Ratios KEQU's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jan 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jan 31 2025 Receivable at quarter ending Jan 31 2025
National Healthcare Corp  10.43 $ 1,307.382  Millions$ 125.362  Millions
Sunlink Health Systems Inc   10.39 $ 31.927  Millions$ 3.073  Millions
Rockwell Medical inc   10.38 $ 101.484  Millions$ 9.778  Millions
Lftd Partners Inc   10.34 $ 37.325  Millions$ 3.611  Millions
Equillium Inc   10.31 $ 41.095  Millions$ 3.988  Millions
Fractyl Health Inc   10.05 $ 0.093  Millions$ 0.009  Millions
Sunshine Biopharma Inc   10.04 $ 34.874  Millions$ 3.472  Millions
Beyond Air Inc   10.02 $ 4.527  Millions$ 0.452  Millions
Quidelortho Corp  9.95 $ 2,782.900  Millions$ 279.625  Millions
Immucell Corp  9.95 $ 26.493  Millions$ 2.663  Millions
Lensar Inc   9.82 $ 53.494  Millions$ 5.447  Millions
Neurometrix Inc   9.81 $ 2.680  Millions$ 0.273  Millions
Dih Holding Us Inc   9.79 $ 112.019  Millions$ 11.440  Millions
Nexgel Inc   9.77 $ 7.748  Millions$ 0.793  Millions
Lipella Pharmaceuticals Inc   9.75 $ 0.536  Millions$ 0.055  Millions
Inogen Inc   9.59 $ 335.705  Millions$ 35.014  Millions
Inspire Medical Systems inc   9.58 $ 801.818  Millions$ 83.715  Millions
American Oncology Network Inc   9.50 $ 1,759.484  Millions$ 185.223  Millions
Alpha Pro Tech Ltd   9.49 $ 56.933  Millions$ 6.002  Millions
Genedx Holdings Corp   9.45 $ 305.397  Millions$ 32.324  Millions
United Therapeutics Corporation  9.44 $ 2,877.400  Millions$ 304.775  Millions
Surmodics Inc   9.39 $ 122.773  Millions$ 13.074  Millions
Travere Therapeutics Inc   9.38 $ 233.175  Millions$ 24.871  Millions
Ensysce Biosciences Inc   9.36 $ 5.210  Millions$ 0.557  Millions
Twist Bioscience Corporation  9.29 $ 330.189  Millions$ 35.550  Millions
Siga Technologies Inc  9.20 $ 138.719  Millions$ 15.084  Millions
Biotricity Inc   9.15 $ 13.095  Millions$ 1.431  Millions
Tandem Diabetes Care Inc   9.10 $ 939.574  Millions$ 103.214  Millions
Encompass Health Corporation  9.01 $ 5,373.200  Millions$ 596.050  Millions
Novocure Limited  8.93 $ 605.220  Millions$ 67.770  Millions

Date modified: 2025-03-16T18:30:23+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com